Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Mol Sci ; 21(12)2020 Jun 24.
Article in English | MEDLINE | ID: mdl-32599772

ABSTRACT

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) protein is expressed at the apical plasma membrane (PM) of different epithelial cells. The most common mutation responsible for the onset of cystic fibrosis (CF), F508del, inhibits the biosynthesis and transport of the protein at PM, and also presents gating and stability defects of the membrane anion channel upon its rescue by the use of correctors and potentiators. This prompted a multiple drug strategy for F508delCFTR aimed simultaneously at its rescue, functional potentiation and PM stabilization. Since ganglioside GM1 is involved in the functional stabilization of transmembrane proteins, we investigated its role as an adjuvant to increase the effectiveness of CFTR modulators. According to our results, we found that GM1 resides in the same PM microenvironment as CFTR. In CF cells, the expression of the mutated channel is accompanied by a decrease in the PM GM1 content. Interestingly, by the exogenous administration of GM1, it becomes a component of the PM, reducing the destabilizing effect of the potentiator VX-770 on rescued CFTR protein expression/function and improving its stabilization. This evidence could represent a starting point for developing innovative therapeutic strategies based on the co-administration of GM1, correctors and potentiators, with the aim of improving F508del CFTR function.


Subject(s)
Adjuvants, Immunologic/pharmacology , Aminophenols/pharmacology , Aminopyridines/pharmacology , Benzodioxoles/pharmacology , Cystic Fibrosis/drug therapy , G(M1) Ganglioside/pharmacology , Quinolones/pharmacology , Adjuvants, Immunologic/chemistry , Aminophenols/chemistry , Bronchi/drug effects , Bronchi/metabolism , Bronchi/pathology , Chloride Channel Agonists/chemistry , Chloride Channel Agonists/pharmacology , Cystic Fibrosis/genetics , Cystic Fibrosis/pathology , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Epithelial Cells/pathology , G(M1) Ganglioside/chemistry , Humans , Mutation , Quinolones/chemistry , Therapies, Investigational
2.
Glycoconj J ; 35(4): 397-402, 2018 08.
Article in English | MEDLINE | ID: mdl-30145639

ABSTRACT

Sphingolipid metabolism is an intricate network of several interdependent and co-regulated pathways. In addition to the mainstream biosynthetic and catabolic pathways, several processes, even if less important in contributing to the final tissue sphingolipid composition from the quantitative point of view, might become relevant when sphingolipid metabolism is for any reason dysregulated and concur to the onset of neuronal pathologies. The main subcellular sites involved in the mainstream metabolic pathway are represented by the Golgi apparatus (for the biosynthesis) and by the lysosomes (for catabolism). On the other hand, the minor collateral pathways are associated with the plasma membrane and membranes of other organelles, and likely play important roles in the local regulation of membrane dynamics and contribute to maintain a perfect membrane organization functional to the physiology of the cell. In this review, we will consider few aspects of the sphingolipid metabolic pathway depending by the dynamic of the membranes that seems to become relevant in neurodegenerative diseases.


Subject(s)
Cell Membrane/metabolism , Golgi Apparatus/metabolism , Lysosomes/metabolism , Nervous System Diseases/metabolism , Neurons/metabolism , Sphingolipids/metabolism , Animals , Cell Membrane/genetics , Cell Membrane/pathology , Golgi Apparatus/genetics , Golgi Apparatus/pathology , Humans , Lysosomes/genetics , Lysosomes/pathology , Nervous System Diseases/genetics , Nervous System Diseases/pathology , Neurons/pathology , Sphingolipids/genetics
3.
Methods Mol Biol ; 1804: 383-400, 2018.
Article in English | MEDLINE | ID: mdl-29926419

ABSTRACT

Cell plasma membrane gangliosides content and pattern is finely regulated by a complex metabolic machinery. Among different pathways, past and new evidence suggests an important role of the sphingolipid catabolic enzymes associated with both lysosomes and plasma membrane. Over the years, several cell-free and cell-based assays are developed in order to evaluate the activities both intracellularly and at the cell surface. Here, we propose a selection of the most efficient, sensitive, and specific assays that allow determining the activity of the main gangliosides-glycohydrolases such as sialidases, ß-hexosaminidases, ß-galactosidases, and ß-glucosidases in both cell/tissue lysates and directly in living cells.


Subject(s)
Enzyme Assays/methods , Gangliosides/metabolism , Animals , Cell Membrane/metabolism , Cells, Cultured , Glucosylceramidase/metabolism , Glycoside Hydrolases/metabolism , Humans , Radioactivity , Substrate Specificity , beta-Galactosidase/metabolism
4.
FASEB J ; 32(10): 5685-5702, 2018 10.
Article in English | MEDLINE | ID: mdl-29746165

ABSTRACT

Lysosomal accumulation of undegraded materials is a common feature of lysosomal storage diseases, neurodegenerative disorders, and the aging process. To better understand the role of lysosomal storage in the onset of cell damage, we used human fibroblasts loaded with sucrose as a model of lysosomal accumulation. Sucrose-loaded fibroblasts displayed increased lysosomal biogenesis followed by arrested cell proliferation. Notably, we found that reduced lysosomal catabolism and autophagy impairment led to an increase in sphingolipids ( i.e., sphingomyelin, glucosylceramide, ceramide, and the gangliosides GM3 and GD3), at both intracellular and plasma membrane (PM) levels. In addition, we observed an increase in the lysosomal membrane protein Lamp-1 on the PM of sucrose-loaded fibroblasts and a greater release of the soluble lysosomal protein cathepsin D in their extracellular medium compared with controls. These results indicate increased fusion between lysosomes and the PM, as also suggested by the increased activity of lysosomal glycosphingolipid hydrolases on the PM of sucrose-loaded fibroblasts. The inhibition of ß-glucocerebrosidase and nonlysosomal glucosylceramidase, both involved in ceramide production resulting from glycosphingolipid catabolism on the PM, partially restored cell proliferation. Our findings indicate the existence of a new molecular mechanism underlying cell damage triggered by lysosomal impairment.-Samarani, M., Loberto, N., Soldà, G., Straniero, L., Asselta, R., Duga, S., Lunghi, G., Zucca, F. A., Mauri, L., Ciampa, M. G., Schiumarini, D., Bassi, R., Giussani, P., Chiricozzi, E., Prinetti, A., Aureli, M., Sonnino, S. A lysosome-plasma membrane-sphingolipid axis linking lysosomal storage to cell growth arrest.


Subject(s)
Cell Cycle Checkpoints , Cell Membrane/metabolism , Fibroblasts/metabolism , Lysosomes/metabolism , Sphingolipids/metabolism , Cathepsin D/genetics , Cathepsin D/metabolism , Cell Line , Cell Membrane/genetics , Fibroblasts/cytology , Humans , Lysosomal Membrane Proteins/genetics , Lysosomal Membrane Proteins/metabolism , Lysosomes/genetics , Sphingolipids/genetics
5.
J Leukoc Biol ; 103(3): 445-456, 2018 03.
Article in English | MEDLINE | ID: mdl-29345379

ABSTRACT

Sphingolipids (SLs) are amphiphilic molecules mainly associated with the external leaflet of eukaryotic plasma membrane, and are structural membrane components with key signaling properties. Since the beginning of the last century, a large number of papers described the involvement of these molecules in several aspects of cell physiology and pathology. Several lines of evidence support the critical role of SLs in inflammatory diseases, by acting as anti- or pro-inflammatory mediators. They are involved in control of leukocyte activation and migration, and are recognized as essential players in host response to pathogenic infection. We propose here a critical overview of current knowledge on involvement of different classes of SLs in inflammation, focusing on the role of simple and complex SLs in pathogen-mediated inflammatory response.


Subject(s)
Bacterial Infections/immunology , Inflammation/immunology , Leukocytes/immunology , Sphingolipids/metabolism , Animals , Bacterial Infections/metabolism , Bacterial Infections/microbiology , Humans , Inflammation/metabolism , Inflammation/pathology , Leukocytes/metabolism , Leukocytes/pathology , Signal Transduction
6.
Mediators Inflamm ; 2017: 1730245, 2017.
Article in English | MEDLINE | ID: mdl-29333001

ABSTRACT

Cystic fibrosis (CF) is the most common autosomal genetic recessive disease caused by mutations of gene encoding for the cystic fibrosis transmembrane conductance regulator. Patients with CF display a wide spectrum of symptoms, the most severe being chronic lung infection and inflammation, which lead to onset of cystic fibrosis lung disease. Several studies indicate that sphingolipids play a regulatory role in airway inflammation. The inhibition and downregulation of GBA2, the enzyme catabolizing glucosylceramide to ceramide, are associated with a significant reduction of IL-8 production in CF bronchial epithelial cells. Herein, we demonstrate that GBA2 plays a role in the proinflammatory state characterizing CF cells. We also report for the first time that Pseudomonas aeruginosa infection causes a recruitment of plasma membrane-associated glycosphingolipid hydrolases into lipid rafts of CuFi-1-infected cells. This reorganization of cell membrane may be responsible for activation of a signaling cascade, culminating in aberrant inflammatory response in CF bronchial epithelial cells upon bacterial infection. Taken together, the presented data further support the role of sphingolipids and their metabolic enzymes in controlling the inflammatory response in CF.


Subject(s)
Cystic Fibrosis/metabolism , Cystic Fibrosis/microbiology , Glycoside Hydrolases/metabolism , Pseudomonas Infections/metabolism , Sphingolipids/metabolism , beta-Glucosidase/metabolism , Bronchi/metabolism , Bronchi/microbiology , Cell Line , Cell Membrane/metabolism , Cell Membrane/microbiology , Cystic Fibrosis/complications , Glucosylceramidase , Humans , Inflammation Mediators/metabolism , Membrane Microdomains/metabolism , Models, Biological , Pseudomonas Infections/complications , Respiratory Mucosa/metabolism , Respiratory Mucosa/microbiology , Signal Transduction
7.
Chem Phys Lipids ; 200: 94-103, 2016 10.
Article in English | MEDLINE | ID: mdl-27592248

ABSTRACT

Cystic fibrosis (CF), one of the most common lethal hereditary diseases of white European populations, is caused by loss-of-function mutations in the CF Transmembrane conductance Regulator (CFTR) gene. One of the main causes of mortality is the onset of CF lung disease, which is characterized by chronic infection and inflammation resulting in the progressive remodelling, irreversible damage and fibrosis of the airways. An increasing number of studies indicate that sphingolipids are crucial players in pulmonary manifestations of CF, even if their direct involvement in CF lung disease is still unclear. In this review, we give an overview of the role of sphingolipids in CF pulmonary disease, focusing on the relationship between glycosphingolipids and lung inflammation, which represents the main hallmark of this disease.


Subject(s)
Cystic Fibrosis/metabolism , Sphingolipids/metabolism , Animals , Humans , Inflammation/metabolism
8.
Eur J Hum Genet ; 24(11): 1578-1583, 2016 11.
Article in English | MEDLINE | ID: mdl-27026573

ABSTRACT

ASAH1 gene encodes for acid ceramidase that is involved in the degradation of ceramide into sphingosine and free fatty acids within lysosomes. ASAH1 variants cause both the severe and early-onset Farber disease and rare cases of spinal muscular atrophy (SMA) with progressive myoclonic epilepsy (SMA-PME), phenotypically characterized by childhood onset of proximal muscle weakness and atrophy due to spinal motor neuron degeneration followed by occurrence of severe and intractable myoclonic seizures and death in the teenage years. We studied two subjects, a 30-year-old pregnant woman and her 17-year-old sister, affected with a very slowly progressive non-5q SMA since childhood. No history of seizures or myoclonus has been reported and EEG was unremarkable. The molecular study of ASAH1 gene showed the presence of the homozygote nucleotide variation c.124A>G (r.124a>g) that causes the amino acid substitution p.Thr42Ala. Biochemical evaluation of cultured fibroblasts showed both reduction in ceramidase activity and accumulation of ceramide compared with the normal control. This study describes for the first time the association between ASAH1 variants and an adult SMA phenotype with no myoclonic epilepsy nor death in early age, thus expanding the phenotypic spectrum of ASAH1-related SMA. ASAH1 molecular analysis should be considered in the diagnostic testing of non-5q adult SMA patients.


Subject(s)
Acid Ceramidase/genetics , Epilepsies, Myoclonic/genetics , Muscular Atrophy, Spinal/genetics , Mutation, Missense , Phenotype , Acid Ceramidase/metabolism , Adolescent , Adult , Cells, Cultured , Epilepsies, Myoclonic/diagnosis , Female , Homozygote , Humans , Muscular Atrophy, Spinal/diagnosis , Pregnancy , Siblings
9.
Clin Chim Acta ; 438: 171-7, 2015 Jan 01.
Article in English | MEDLINE | ID: mdl-25172040

ABSTRACT

BACKGROUND: Amongst the newly proposed biomarkers for ovarian cancer, serum human epididymis protein 4 (HE4) shows the greatest potential for clinical use. However, systematic appraisals of its biological characteristics are not available. This study sought to critically revise the available literature on biological and lifestyle factors affecting HE4 concentrations in serum to understand their possible influence on the marker interpretation. METHODS: A literature search was undertaken on electronic databases and references from retrieved articles. Article results were analyzed by evaluating study design, sample size, statistical approach, employed assay and, when available, by collecting similar information for carbohydrate antigen 125 (CA-125). RESULTS: Several factors may influence serum HE4 concentrations. In contrast to CA-125, higher HE4 concentrations are reported in the elderly. Although no variations in HE4 concentrations can be clearly associated to menopausal status, a strong difference in biomarker biological intra-individual variation according to the fertility status is reported. Smoking and renal function can also significantly influence HE4 results. CONCLUSION: The knowledge of factors influencing HE4 concentrations is relevant to promote more adequate interpretative criteria for use of this biomarker in the clinical setting.


Subject(s)
Biomarkers, Tumor/analysis , Ovarian Neoplasms/diagnosis , Ovarian Neoplasms/metabolism , Proteins/analysis , Biomarkers, Tumor/metabolism , Female , Humans , Proteins/metabolism , WAP Four-Disulfide Core Domain Protein 2
SELECTION OF CITATIONS
SEARCH DETAIL
...